| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8340835 | Microvascular Research | 2018 | 23 Pages |
Abstract
When Tyr is administered to young SHRs during the development of hypertension, it limits the development of hyperviscosity syndrome, improves the oxygen transport capacity and eliminates microvascular rarefaction in the cerebral cortex.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Mark B. Plotnikov, Oleg I. Aliev, Anastasia V. Sidekhmenova, Alexander Y. Shamanaev, Anna M. Anishchenko, Tatiana I. Fomina, Tatiana M. Plotnikova, Alexander M. Arkhipov,